E-Journal of Chemistry p. 1346 - 1354 (2011)
Update date:2022-08-05
Topics:
Mathew, Glory
Krishnan
Antony, Molly
Suseelan
Copper(II) complexes of chromen-2-one-3-carboxyhydrazide and 2-(chromen-3'-onyl)-5-(aryl)-1,3,4-oxadiazole derivatives have been synthesized. The structural features have been determined from their microanalytical, magnetic susceptibility, molar conductance, IR, UV Vis, 1H NMR and ESR spectral data. All the Cu(II) complexes exhibit the composition Cu(Ln) 2X2; where L1= chromen-2-one-3-carboxy hydrazide, L2 = 2-(chromen-3'-onyl)- 5-(2"-hydroxy phenyl)-1,3,4-oxadiazole, L3 = 2-(chromen-3'-onyl)-5-(4"- nitrophenyl)-1,3,4 -oxadiazole and L4 = 2-(chromen-3'-onyl)-5-(4"- chlorophenyl)-1,3,4-oxadiazole; X = Cl-, Br-, NO3 -, CH3COO-, ClO4 - and CNS-. The N, O donor ligands act as a bidentate ligand in all the complexes. Distorted octahedral geometry for all the Cu(II) complexes is proposed. Molecular modeling studies have been made for the rapid structure building, geometry optimization and molecular display. These complexes show the conductance values, supporting their non-electrolytic nature. The monomeric nature of the complexes was confirmed from their magnetic susceptibility values. These complexes have been screened for their antimicrobial activities against some bacterial species like S.aureus, E.coli, Pseudomonas aeruginosa and few fungal strains C.albicans and Cryptococcus neoformans.
View MoreContact:+86-519-86339586,13584329896
Address:Changzhou Scientific and Education Park
Huangshi Meifeng Chemical Co.,ltd.
Contact:+86-714-6516706
Address:1941-4-3#,Hubin Avenue,Huangshi,Hubei,China
Huludao Tianqi Shengye Chemical Co.,Ltd.
Contact:0086 429 2075777
Address:Area B,Shipbuilding Industry Park,Beigang District,Huludao City,Liaoning prov.,China
SHIJIAZHUANG HENRYTE CHEMICALS CO,.LTD(expird)
Contact:+86-311-85208698 311-80837698
Address:NO.166, yuhua west road, SHIJIAZHUANG, China
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Doi:10.1039/j29710001988
(1971)Doi:10.1016/S0960-894X(00)00465-0
(2000)Doi:10.7164/antibiotics.53.1086
(2000)Doi:10.1021/jo0000170
(2000)Doi:10.1021/jo00822a016
(1971)Doi:10.1039/j39710000861
(1971)